ScoreNeurology
Modified Erasmus GBS Outcome Score (mEGOS) at hospital admission
Predicts the probability of being unable to walk unaided at 4 weeks, 3 and 6 months in Guillain-Barré syndrome.
Updated 31 October 2026
When to use it
Patients with Guillain-Barré syndrome at hospital admission, to estimate motor prognosis, inform families and select patients for trials.
What it needs
- Age at symptom onset
- Diarrhoea in the 4 weeks before weakness
- MRC sum score at hospital admission
The points for each answer and the automatic total are in the app.
How to interpret it
The result is read in its clinical context; the app shows it with its units and warnings.
Practical tip
The higher the score, the higher the probability of not walking independently; exact probabilities are read from the curves in the original article.
3 more practical tips in the app.
Reference
- Walgaard C, Lingsma HF, Ruts L, van Doorn PA, Steyerberg EW, Jacobs BC. Early recognition of poor prognosis in Guillain-Barré syndrome. Neurology. 2011;76(11):968-975.
- Doets AY, Lingsma HF, Walgaard C, et al. Predicting outcome in Guillain-Barré syndrome: international validation of the modified Erasmus GBS Outcome Score. Neurology. 2022;98(5):e518-e532.
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
